The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions

NCT ID: NCT02496052

Last Updated: 2015-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To estimate the efficacy and safety of dried biological amnion graft after hysteroscopic lysis of intrauterine adhesions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Prevention

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrauterine Adhesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dried biological amnion graft

patients, who are with IUA, treated by uterine application of amnion membrane + Foley balloon+ hormones (estradiol valerate tablets+dydrogesterone Tablets) following hysteroscopic adhesiolysis.

Group Type EXPERIMENTAL

dried biological amnion graft

Intervention Type PROCEDURE

Uterine application of amnion membrane following hysteroscopic adhesiolysis. Other Name: Human amnion membrane

Foley balloon

Intervention Type DEVICE

Device: Foley balloon Uterine application of Foley balloon

estradiol valerate tablets+dydrogesterone Tablets

Intervention Type DRUG

oral estradiol valerate tablets+dydrogesterone Tablets

Foley catheter balloon only

patients, who are with IUA, treated by uterine application of Foley balloon only+ hormones (estradiol valerate tablets+dydrogesterone Tablets) following hysteroscopic adhesiolysis.

Group Type SHAM_COMPARATOR

Foley balloon

Intervention Type DEVICE

Device: Foley balloon Uterine application of Foley balloon

estradiol valerate tablets+dydrogesterone Tablets

Intervention Type DRUG

oral estradiol valerate tablets+dydrogesterone Tablets

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dried biological amnion graft

Uterine application of amnion membrane following hysteroscopic adhesiolysis. Other Name: Human amnion membrane

Intervention Type PROCEDURE

Foley balloon

Device: Foley balloon Uterine application of Foley balloon

Intervention Type DEVICE

estradiol valerate tablets+dydrogesterone Tablets

oral estradiol valerate tablets+dydrogesterone Tablets

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Uterine application of amnion membrane Device: Foley balloon Uterine application of Foley balloon Progynova+dydrogesterone

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 20-40 years;
* previously diagnostic hysteroscopy confirmed adhesion score \>5, according to the American Fertility Society (AFS)classification of IUA;
* complains of menstruation disorder and reproductive dysfunction;
* informed consent.

Exclusion Criteria

* premature menopause,
* presence of other intrauterine lesions (e.g. polyps, myoma, septa), and
* presence of severe intercurrent illness (e.g. systemic disease, coagulative disorders, severe kidney and liver diseases),
* adhesions limited to the lower uterine cavity or the cervical canal.
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Obstetrics and Gynecology Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Duan Hua, Ph.D

Role: STUDY_CHAIR

Beijing Obstetrics and Gynecology Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Obstetrics and Gynecology Hospital,Capital Medical University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wang Xin, MD

Role: CONTACT

13681401510

Gan Lu, MD

Role: CONTACT

13552320665

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liu Zhen, M.D

Role: primary

+8613718210767

References

Explore related publications, articles, or registry entries linked to this study.

Amer MI, Abd-El-Maeboud KH. Amnion graft following hysteroscopic lysis of intrauterine adhesions. J Obstet Gynaecol Res. 2006 Dec;32(6):559-66. doi: 10.1111/j.1447-0756.2006.00454.x.

Reference Type RESULT
PMID: 17100817 (View on PubMed)

Gan L, Duan H, Sun FQ, Xu Q, Tang YQ, Wang S. Efficacy of freeze-dried amnion graft following hysteroscopic adhesiolysis of severe intrauterine adhesions. Int J Gynaecol Obstet. 2017 May;137(2):116-122. doi: 10.1002/ijgo.12112. Epub 2017 Mar 1.

Reference Type DERIVED
PMID: 28170094 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-1-2112

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

zylx201406

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

NO.1-20140601

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.